login

Lymphatic Filariasis Control in Tanzania: Effect of Repeated Mass Drug Administration with Ivermectin and Albendazole on Infection and Transmission

PLoS neglected tropical diseasesPublished 1 June 2010Open access
Paul E. Simonsen, Erling M Pedersen, Rwehumbiza T. Rwegoshora, Mwelecele N. Malecela, Yahya A. Derua, Stephen Magesa
Citations120
SJR quartileQ1
SJR score1.37
SNIP1.44
View PDF

TL;DR

The findings highlight the importance of ongoing surveillance for monitoring the progress of LF control programmes, and calls for more research into the long-term effect of repeated ivermectin/albendazole MDAs (including the significance of treatment intervals and compliance), in order to optimize efforts to control LF in sub-Saharan Africa.

Abstract

Critical issues that may potentially explain the observed waning effect of the MDAs in the later study period include the long intervals between MDAs and a lower than optimal treatment coverage. The findings highlight the importance of ongoing surveillance for monitoring the progress of LF control programmes, and it calls for more research into the long-term effect of repeated ivermectin/albendazole MDAs (including the significance of treatment intervals and compliance), in order to optimize efforts to control LF in sub-Saharan Africa.

Keywords

Immunology and MicrobiologyMedicineEnvironmental Science